|
Index of reports
> Cases resulting in life threatening events (36)
Below is the selection of adverse event reports related to Aldactone (Spironolactone) that includes cases resulting in life threatening events.
Reports 1 - 25 of 36 Next >>
Adverse event in female receiving Aldactone (Spironolactone)
Reported by a consumer/non-health professional from Brazil on 2007-10-26
Patient: female
Adverse reactions / side effects: Syncope, Dyspnoea, Injection Site Haematoma, Coagulopathy, Oedema, Arterial Occlusive Disease, Pulmonary Oedema, Depression, Myocardial Infarction, Blood Glucose Increased
Adverse event resulted in: life threatening event, hospitalization, disablity
Suspect drug(s):
Diabinese
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 1996-01-01
End date: 2004-11-30
Norvasc
Administration route: Oral
Start date: 2004-01-01
End date: 2006-01-01
Caduet
Dosage: text:10mg/5mg;20mg/10mg
Administration route: Oral
Indication: Hypertension
Aldactone
Administration route: Oral
Indication: Hypertension
Olmetec
Administration route: Oral
Indication: Hypertension
Coristina D
Administration route: Oral
Indication: Influenza
Insulin
Indication: Diabetes Mellitus
Start date: 2004-11-01
Novonorm
Adverse event in 62 year old female receiving Aldactone (Spironolactone)
Reported by a physician from Japan on 2007-10-12
Patient: 62 year old female
Adverse reactions / side effects: Pulmonary Embolism, Deep Vein Thrombosis
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Aldactone (Spironolactone)
Other drugs received by patient: NU Lotan; Mercazole
Adverse event in 57 year old male receiving Aldactone (Spironolactone)
Reported by a pharmacist from Japan on 2007-10-02
Patient: 57 year old male, weighing 59.0 kg (129.8 pounds)
Adverse reactions / side effects: White Blood Cell Count Decreased, Dyspnoea, Pericardial Effusion, Haemoglobin Decreased, Haematocrit Decreased, Thrombocytopenic Purpura, Platelet Count Decreased, Haemorrhagic Diathesis, Rash Maculo-Papular
Adverse event resulted in: life threatening event
Suspect drug(s):
Lasix
Dosage: 20 mg/day
Administration route: Oral
Indication: Cardiac Failure Congestive
Start date: 2007-06-12
End date: 2007-07-13
Aldactone
Dosage: 25 mg/day
Administration route: Oral
Indication: Cardiac Failure Congestive
Start date: 2007-06-27
End date: 2007-07-20
Tenormin
Dosage: 25 mg/day
Administration route: Oral
Indication: Atrial Fibrillation
Start date: 2004-04-01
End date: 2007-07-20
Micardis
Dosage: 20 mg/day
Administration route: Oral
Indication: Cardiac Failure Congestive
Start date: 2004-04-01
End date: 2007-07-20
Warfarin Sodium
Dosage: 3 mg/day
Administration route: Oral
Indication: Atrial Fibrillation
Start date: 2007-06-07
End date: 2007-07-09
Propylthiouracil
Dosage: 300 mg/day
Administration route: Oral
Start date: 1987-01-01
End date: 2007-07-12
Propylthiouracil
Dosage: 200 mg/day
Administration route: Oral
Start date: 2007-07-13
End date: 2007-07-20
Propylthiouracil
Dosage: 300 mg/day
Administration route: Oral
Start date: 2007-08-03
Mucosta
Dosage: 300 mg/day
Administration route: Oral
Indication: Gastric Mucosal Lesion
Start date: 2007-05-18
End date: 2007-07-13
Sigmart
Dosage: 15 mg/day
Administration route: Oral
Indication: Angina Pectoris
Start date: 2004-04-01
End date: 2007-07-13
Bepricor
Dosage: 150 mg/day
Administration route: Oral
Indication: Atrial Fibrillation
Start date: 2007-07-02
End date: 2007-07-20
Nitroderm
Dosage: 1 patch/day
Indication: Angina Pectoris
Start date: 2007-07-13
Amlodipine Besylate
Indication: Angina Pectoris
Start date: 2004-04-01
Aspirin
Dosage: 100mg
Administration route: Oral
End date: 2007-07-12
Other drugs received by patient: Unasyn; Gentacin
Adverse event in female receiving Aldactone (Spironolactone)
Reported by a physician from Japan on 2007-07-24
Patient: female, weighing 61.5 kg (135.3 pounds)
Adverse reactions / side effects: Hyperkalaemia, Bradyarrhythmia, Hypotension
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Aldactone
Administration route: Oral
Indication: Cardiac Failure
Start date: 2007-02-01
End date: 2007-06-27
Micardis
Indication: Hypertension
Start date: 2005-01-01
End date: 2007-06-27
Other drugs received by patient: Amaryl; Basen; Aspirin; Lasix; Artist; Frandol; Magnesium Oxide
Adverse event in female receiving Aldactone (Spironolactone)
Reported by a health professional (non-physician/pharmacist) from France on 2007-07-20
Patient: female, weighing 7.0 kg (15.4 pounds)
Adverse reactions / side effects: Bradycardia, Cardiac Arrest
Adverse event resulted in: life threatening event
Suspect drug(s):
Aldactone
Indication: Varices Oesophageal
Aetoxisclerol
Dosage: text:tdd:2 df
Indication: Varices Oesophageal
Other drugs received by patient: Propranolol Hydrochloride; Omeprazole; Targocid
Adverse event in male receiving Aldactone (Spironolactone)
Reported by a physician from Japan on 2007-07-16
Patient: male
Adverse reactions / side effects: Toxic Epidermal Necrolysis
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Aldactone
Dosage: daily dose:50mg-freq:frequency: bid
Indication: Oedema
Start date: 2007-05-08
End date: 2007-05-21
Soldactone
Dosage: daily dose:200mg
Indication: Oedema
Start date: 2007-04-25
End date: 2007-05-07
Soldactone
Indication: Ascites
Other drugs received by patient: Lasix; Pariet; Magnesium Oxide; Livact; Lactulose
Adverse event in 85 year old female receiving Aldactone (Spironolactone)
Reported by a pharmacist from Spain on 2007-07-06
Patient: 85 year old female, weighing 55.0 kg (121.0 pounds)
Adverse reactions / side effects: Syncope, Hyperkalaemia, Dizziness, Drug Interaction, Renal Failure Acute
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Aldactone (Spironolactone)
Other drugs received by patient possibly interacting with the suspect drug:
Olmesartan Medoxomil
Administration route: Oral
Indication: Hypertension
Start date: 2006-02-07
End date: 2007-05-15
Other drugs received by patient: Amitriptyline HCL; Omeprazole; Ferrous Sulfate; Folic Acid; Diltiazem
Adverse event in 85 year old female receiving Aldactone (Spironolactone)
Reported by a pharmacist from Spain on 2007-07-05
Patient: 85 year old female, weighing 55.0 kg (121.0 pounds)
Adverse reactions / side effects: Syncope, Drug Interaction, Renal Failure Acute
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Ixia (Olmesartan Medoxomil) (20 Milligram, Tablet) (Olmesartan Medoxom
Dosage: 20 mg (20 mg, 1 tab daily) per oral
Administration route: Oral
Indication: Hypertension
Start date: 2006-02-07
End date: 2007-05-15
Aldactone
Dosage: 100 mg (100 mg, 1 tab daily), per oral
Administration route: Oral
Indication: Hypertension
Start date: 2006-02-07
End date: 2007-05-15
Other drugs received by patient: Tryptizol (Amitriptyline Hydrochloride) (Amitriptyline Hydrochloride); Omeprazol (Omeprazole) (Omeprazole); Fero-Gradumet (Ferrous Sulfate) (Ferrous Sulfate); Acfol (Folic Acid) (Folic Acid); Carreldon Retard (Diltiazem) (Diltiazem)
Adverse event in 82 year old female receiving Aldactone (Spironolactone)
Reported by a individual with unspecified qualification from Japan on 2007-07-02
Patient: 82 year old female, weighing 56.0 kg (123.2 pounds)
Adverse reactions / side effects: Hyperkalaemia, Feeling Cold, Blood Pressure Inadequately Controlled, Sinus Arrest, Blood Creatinine Increased, White Blood Cell Count Increased, Renal Failure Acute, Ventricular Extrasystoles, Blood Urea Increased, Muscular Weakness, Blood Potassium Increased, Blood Bicarbonate Decreased, Computerised Tomogram Abnormal, Tremor, Haemodialysis, Haemoglobin Decreased, Anorexia, Renal Hypertension, Electrocardiogram Abnormal, Bradycardia, Gait Disturbance, Blood Pressure Decreased, Asthenia
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Diovan
Dosage: 80 mg, qd
Administration route: Oral
Indication: Hypertension
Start date: 2002-12-01
Diovan
Start date: 2002-12-12
End date: 2003-01-06
Trandolapril
Administration route: Oral
Indication: Hypertension
Start date: 1982-01-01
Spironolactone
Dosage: unk, unk
Administration route: Oral
Indication: Hypertension
Start date: 2002-11-01
Odrik
Dosage: 2 mg/day
Administration route: Oral
Indication: Hypertension
Start date: 1997-11-06
End date: 2003-01-06
Aldactone
Dosage: 25 mg/day
Administration route: Oral
Indication: Hypertension
Start date: 2002-11-18
End date: 2003-01-06
Landel
Dosage: 60 mg/day
Administration route: Oral
Indication: Hypertension
Start date: 2001-02-27
End date: 2003-01-06
Landel
Dosage: 20 mg/day
Administration route: Oral
Start date: 2003-01-10
Salobel
Dosage: 100 mg/day
Administration route: Oral
Indication: Hyperuricaemia
Start date: 1997-02-25
End date: 2003-01-06
Pimenol
Dosage: 100 mg/day
Administration route: Oral
Indication: Ventricular Arrhythmia
Start date: 1997-11-06
End date: 2003-01-06
Adverse event in 45 year old female receiving Aldactone (Spironolactone)
Reported by a pharmacist from Japan on 2007-06-19
Patient: 45 year old female
Adverse reactions / side effects: Breast Cancer
Adverse event resulted in: life threatening event
Suspect drug(s):
Aldactone (Spironolactone)
Other drugs received by patient: Ferromia; Metoprolol Tartrate; Lopemin; Merislon; Cimetidine HCL; Biofermin; Tamoxifen Citrate; Aspara; Novamin
Adverse event in male receiving Aldactone (Spironolactone)
Reported by a physician from Japan on 2007-06-15
Patient: male
Adverse reactions / side effects: Toxic Epidermal Necrolysis
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Aldactone
Dosage: daily dose:50mg-freq:frequency: bid
Indication: Oedema
Start date: 2007-05-08
End date: 2007-05-21
Soldactone
Dosage: daily dose:200mg
Indication: Oedema
Start date: 2007-04-25
End date: 2007-05-07
Soldactone
Indication: Ascites
Other drugs received by patient: Lasix; Pariet; Magnesium Oxide; Livact; Lactulose
Adverse event in male receiving Aldactone (Spironolactone)
Reported by a physician from Japan on 2007-06-11
Patient: male
Adverse reactions / side effects: Toxic Epidermal Necrolysis
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Aldactone
Dosage: daily dose:50mg-freq:frequency: bid
Indication: Oedema
Start date: 2007-05-08
End date: 2007-05-21
Soldactone
Dosage: daily dose:200mg
Indication: Oedema
Start date: 2007-04-25
End date: 2007-05-07
Soldactone
Indication: Ascites
Other drugs received by patient: Lasix; Pariet; Magnesium Oxide; Livact; Lactulose
Adverse event in 76 year old male receiving Aldactone (Spironolactone)
Reported by a physician from Japan on 2007-06-01
Patient: 76 year old male
Adverse reactions / side effects: Toxic Epidermal Necrolysis
Adverse event resulted in: life threatening event
Suspect drug(s):
Aldactone
Dosage: daily dose:50mg
Start date: 2007-05-08
End date: 2007-05-21
Soldactone
Dosage: daily dose:200mg
Start date: 2007-04-25
End date: 2007-05-07
Other drugs received by patient: Lasix; Pariet
Adverse event in 61 year old female receiving Aldactone (Spironolactone)
Reported by a consumer/non-health professional from United States on 2007-05-29
Patient: 61 year old female, weighing 65.3 kg (143.7 pounds)
Adverse reactions / side effects: Confusional State, Hypokalaemia, Fatigue, Vitreous Floaters, Dizziness, Thrombocytopenia, Thyroid Function Test Abnormal, Hepatic Cirrhosis, White Blood Cell Count Decreased, Nausea, Blood Chloride Decreased, Anaemia, Hypotension, Hyponatraemia, Bursitis, Haemoglobin Decreased, Arthralgia, Diarrhoea, Dehydration, Platelet Count Decreased, Neutropenia, Asthenia, Neutrophil Count Decreased
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Pegasys
Dosage: patient was off therapy for ten days.
Start date: 2006-04-26
Pegasys
End date: 2006-11-01
Pegasys
Start date: 2006-11-01
Pegasys
End date: 2007-02-01
Pegasys
Start date: 2007-02-01
Ribavirin
Dosage: frequency reported as 5/d. patient was off therapy for ten days.
Administration route: Oral
Start date: 2006-04-26
Ribavirin
Dosage: frequency reported as 5/d.
Administration route: Oral
Hydrochlorothiazide
Dosage: drug reported as spironolactone aldactone/ hctz. strength reported as 25. frequency reported as 2/d.
Administration route: Oral
Indication: Hypertension
End date: 2006-05-26
Aldactone
Administration route: Oral
Indication: Hypertension
End date: 2006-05-26
Other drugs received by patient: Synthroid
Adverse event in 77 year old female receiving Aldactone (Spironolactone)
Reported by a pharmacist from Spain on 2007-05-18
Patient: 77 year old female
Adverse reactions / side effects: Dyspnoea
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Aldactone
Administration route: Oral
Coropres
Administration route: Oral
End date: 2006-05-12
Kalpress
Administration route: Oral
Seguril
Administration route: Oral
Adverse event in 79 year old male receiving Aldactone (Spironolactone)
Reported by a pharmacist from Spain on 2007-05-18
Patient: 79 year old male
Adverse reactions / side effects: Hyperkalaemia
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Aldactone
Dosage: daily dose:100mg-freq:daily
Administration route: Oral
Norvasc
Dosage: daily dose:10mg-freq:daily
Administration route: Oral
Adverse event in 77 year old female receiving Aldactone (Spironolactone)
Reported by a individual with unspecified qualification on 2007-05-14
Patient: 77 year old female
Adverse reactions / side effects: Dyspnoea
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Seguril / 00032601 /
Administration route: Oral
Aldactone
Administration route: Oral
End date: 2006-05-12
Kalpress
Administration route: Oral
End date: 2006-05-12
Coropres
Administration route: Oral
End date: 2006-05-12
Adverse event in 22 year old female receiving Aldactone (Spironolactone)
Reported by a physician from Switzerland on 2007-05-08
Patient: 22 year old female
Adverse reactions / side effects: OFF Label USE, Hyponatraemia, Renal Failure Acute
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Aldactone (Spironolactone)
Other drugs received by patient: Isotretinoin; Surmontil; Abilify; Entumin
Adverse event in 72 year old male receiving Aldactone (Spironolactone)
Reported by a pharmacist from Spain on 2007-05-03
Patient: 72 year old male
Adverse reactions / side effects: Hyperkalaemia, Atrioventricular Block Complete, Drug Interaction, Renal Failure Acute, Haemodialysis
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Aldactone (Spironolactone)
Other drugs received by patient possibly interacting with the suspect drug:
Renitec
Dosage: daily dose:80mg-text:40 mg twice daily
Administration route: Oral
Indication: Essential Hypertension
Furosemide
Dosage: daily dose:40mg-text:40 mg once daily
Administration route: Oral
Indication: Essential Hypertension
Manidon
Dosage: daily dose:240mg-text:240 mg daily
Administration route: Oral
Indication: Cardiac Disorder
Other drugs received by patient: Allopurinol; Atorvastatin Calcium
Adverse event in 59 year old male receiving Aldactone (Spironolactone)
Reported by a pharmacist from Spain on 2007-05-03
Patient: 59 year old male
Adverse reactions / side effects: Hyperkalaemia, Drug Interaction, Renal Failure Acute
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Aldactone (Spironolactone)
Other drugs received by patient possibly interacting with the suspect drug:
Seguril
Administration route: Oral
Start date: 2007-03-15
End date: 2007-03-22
Antiinflammatory / Antirheumatic NON-Steroids
Dosage: freq:prn
Administration route: Oral
Indication: Arthropathy
Start date: 2007-03-11
End date: 2007-01-01
Other drugs received by patient: Enalapril; Sustiva; Kaletra; Septra; Coropres; Uniket; Adiro; Omeprazole; Ziagen
Adverse event in 72 year old male receiving Aldactone (Spironolactone)
Reported by a individual with unspecified qualification on 2007-04-30
Patient: 72 year old male
Adverse reactions / side effects: Hyperkalaemia, Atrioventricular Block Complete, Haemodialysis, Renal Failure Acute
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Seguril / 00032601 /
Administration route: Oral
Indication: Essential Hypertension
End date: 2006-08-27
Renitec / 00574901 /
Administration route: Oral
Indication: Essential Hypertension
End date: 2006-08-27
Aldactone
Administration route: Oral
Indication: Essential Hypertension
Start date: 2006-07-04
End date: 2006-08-27
Manidon
Administration route: Oral
Indication: Cardiac Disorder
End date: 2006-08-27
Other drugs received by patient: Alopurinol; Zarator / 01326101 /
Adverse event in 59 year old male receiving Aldactone (Spironolactone)
Reported by a individual with unspecified qualification on 2007-04-30
Patient: 59 year old male
Adverse reactions / side effects: Hyperkalaemia, Renal Failure Acute
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Seguril / 00032601 /
Dosage: dose: unknown dosage
Administration route: Oral
Start date: 2007-03-15
End date: 2007-03-22
Aldactone
Dosage: dose: unknown dosage
Administration route: Oral
Start date: 2007-03-15
End date: 2007-03-22
Nsaid's
Dosage: dose: unknown dosage
Administration route: Oral
Start date: 2007-03-11
End date: 2007-01-01
Other drugs received by patient: Enalapril; Sustiva; Kaletra; Septrin; Coropres; Uniket; Adiro; Ziagen; Omeprazole
Adverse event in 82 year old male receiving Aldactone (Spironolactone)
Reported by a individual with unspecified qualification on 2007-04-18
Patient: 82 year old male
Adverse reactions / side effects: Blood Urea Increased, Hyperkalaemia, Hyponatraemia
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Seguril / 00032601 /
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
End date: 2006-03-28
Aldactone
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
End date: 2006-03-28
Adverse event in 95 year old female receiving Aldactone (Spironolactone)
Reported by a health professional (non-physician/pharmacist) from France on 2007-04-16
Patient: 95 year old female
Adverse reactions / side effects: Renal Failure Acute
Adverse event resulted in: death, life threatening event
Suspect drug(s):
Aldactone
Administration route: Oral
Colchimax (France)
Administration route: Oral
Allopurinol
Administration route: Oral
Furosemide
Administration route: Oral
Fozitec
Administration route: Oral
Avandia
Administration route: Oral
Other drugs received by patient: Adancor; Kardegic; Cardensiel; Lasix; Pariet; Stablon; Alprazolam; Zolpidem; Diosmectite; Arestal
Adverse event in 95 year old female receiving Aldactone (Spironolactone)
Reported by a consumer/non-health professional from France on 2007-04-16
Patient: 95 year old female
Adverse reactions / side effects: OFF Label USE, Acute Pulmonary Oedema, Right Ventricular Failure, Cardiac Failure, Hyperkalaemia, Oedema Peripheral, Acidosis, Renal Failure Acute
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Allopurinol
Administration route: Oral
Avandia
Administration route: Oral
Aldactone
Administration route: Oral
Colchimax
Administration route: Oral
Lasix
Administration route: Oral
Fozitec
Administration route: Oral
Other drugs received by patient: Adancor; Kardegic; Cardensiel; Pariet; Stablon; Alprazolam; Zolpidem; Aluminum Hydroxide and Magnesium Trisilicate; Arestal
Page 1 Next >>
|
